Australia markets closed

Veeva Systems Inc. (VEEV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
168.53+1.29 (+0.77%)
At close: 04:00PM EST
169.00 +0.47 (+0.28%)
After hours: 06:15PM EST
Full screen
Trade prices are not sourced from all markets
Previous close167.24
Bid165.43 x 800
Ask169.74 x 1000
Day's range161.78 - 168.60
52-week range151.02 - 274.29
Avg. volume1,053,522
Market cap26.17B
Beta (5Y monthly)0.81
PE ratio (TTM)75.91
EPS (TTM)2.22
Earnings date28 Feb 2023 - 06 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est215.50
  • PR Newswire

    Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific

    Veeva Systems (NYSE: VEEV) today announced findings from the latest Veeva Pulse Field Trends Report, the largest global industry benchmark of its kind on healthcare professional HCP engagement. Asia Pacific data shows that HCP access is limited and the growth of omnichannel engagement, across digital channels is driven by reps building effective relationships through use of relevant content.

  • Motley Fool

    2 Under-the-Radar Tech Stocks to Buy In 2023

    Veeva Systems (NYSE: VEEV) and DigitalOcean (NYSE: DOCN) are both flying under many investors' radar. Each has had a solid 2022, but their stocks haven't performed very well, with Veeva down 34% and DigitalOcean down 65% this year. Veeva Systems is a crossover between a healthcare company and a tech company.

  • Motley Fool

    Is Veeva Systems Stock a Buy Now?

    Veeva Systems' (NYSE: VEEV) stock dipped 4% during after-hours trading on Dec. 1, following its latest earnings report. Its adjusted net income grew 16% to $183.2 million, or $1.13 per share, also topping analysts' estimates by $0.06. It established a first-mover advantage in this niche market, and it was serving more than 1,200 customers worldwide -- including Pfizer, Johnson & Johnson, and Moderna -- at the end of fiscal 2022 (which ended on Jan. 31).